Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1998050037) ANXIOLYTICS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/050037 International Application No.: PCT/JP1998/001954
Publication Date: 12.11.1998 International Filing Date: 28.04.1998
Chapter 2 Demand Filed: 28.04.1998
IPC:
A61K 31/519 (2006.01) ,C07D 495/04 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
495
Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
Applicants:
MITSUBISHI CHEMICAL CORPORATION [JP/JP]; 5-2, Marunouchi 2-chome Chiyoda-ku Tokyo 100-0005, JP (AT, BE, CA, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
EGUCHI, Junichi [JP/JP]; JP (UsOnly)
MORI, Reiko [JP/JP]; JP (UsOnly)
SAITO, Ken-Ichi [JP/JP]; JP (UsOnly)
Inventors:
EGUCHI, Junichi; JP
MORI, Reiko; JP
SAITO, Ken-Ichi; JP
Agent:
IMAMURA, Masazumi @.; KRF Building 5th floor 5-5, Kyobashi 1-chome Chuo-ku Tokyo 104-0031, JP
Priority Data:
9/11552306.05.1997JP
Title (EN) ANXIOLYTICS
(FR) ANXIOLYTIQUES
Abstract:
(EN) Anxiolytics containing as the active ingredient substances selected from the group consisting of [2,3-d]thienopyrimidine derivatives represented by general formula (I), pharmaceutically acceptable salts thereof, and hydrates and solvates of the same. In said formula R1 and R2 each independently represents hydrogen, halogeno or C1-6 alkyl; R3 and R4 each independently represents hydrogen or C1-6 alkyl; R5 represents hydrogen, C1-6 alkyl, etc.; Ar represents optionally substituted phenyl, 2-thienyl or 3-thienyl; and n is an integer of 2 or 3.
(FR) Anxiolytiques contenant en tant qu'ingrédient actif des substances sélectionnées dans le groupe constitué par des dérivés de [2,3-d]thiénopyrimidine représentés par la formule (I), leurs sels acceptables sur le plan pharmaceutique, leurs hydrates et leurs solvates: (I) dans laquelle R1 et R2 représentent chacun indépendamment hydrogène, halogéno ou alkyle C1-C6; R3 et R4 représentent chacun indépendamment hydrogène ou alkyle C1-C6; R5 représente hydrogène, alkyle C1-C6; Ar représente phényle éventuellement substitué, 2-thiényle ou 3-thiényle et n est un entier de 2 ou 3.
front page image
Designated States: CA, US
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)